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BrazzeinThe sweet receptor is a member of the G-protein coupled receptor family C that detects a wide variety of
chemically and structurally diverse sweet-tasting molecules. We recently used saturation transfer difference
spectroscopy (STD) to monitor the direct binding of a set of sweet agonists and antagonists to the human
taste receptor in membranes prepared from human embryonic kidney (HEK293) cells transfected with and
expressing the sweet receptor [F.M. Assadi-Porter, M. Tonelli, E. Maillet, K. Hallenga, O. Benard, M. Max, J.L.
Markley, J. Am. Chem. Soc. 130 (2008) 7212–7213]. Here we review this work and related studies, discuss
the procedures involved, and expand on their potential for identifying speciﬁc binding interactions of ligands
to the membrane spanning and extracellular regions of the full heterodimeric sweet taste receptor. Whereas
activity assays are unable to distinguish mutations that alter ligand-binding sites from those that alter signal
transduction downstream of the binding site, STD NMR now allows us to make this distinction.
© 2009 Published by Elsevier B.V.1. Introduction
1.1. Human heterodimeric sweet receptor
The primary human sweet taste receptor has been identiﬁed as a
heterodimer of twoG-protein coupled receptor (GPCR) subunits, hT1R2
and hT1R3 (human taste type 1 receptor 2 and 3) [1–4]. T1R receptors
are variously called T1R, T1r and Tas1R. At the amino acid level, hT1Rs
have substantial sequence similarity with metabotropic glutamate
receptors (mGluRs), making them members of GPCR family C [5].
Family C GPCRs are hetero- or homodimeric receptors with a large
extracellular region composed of two domains: the Venus ﬂytrap
module (VFTM) and the cysteine-rich domain (CRD) [6]. The VFTM is a
two-lobed clamshell-like structure (Fig. 1). The CRD lies between the
VFTM and the heptahelical transmembrane domain (TMD). The
structure of the CRD and the extracellular regions of the group II/III
metabotropic glutamate receptors was solved recently [7], but its exact
function is still unknown. A disulﬁde bond between one of the nine
highly conserved cysteines in the CRD, located within its span of ~70
residues, and a conserved cysteine in the VFTM have been shown to be
important for signal transduction from a bound ligand [8]. As shown by
an X-ray crystal structure, the homodimeric mGluR1 VFTM consists of
two asymmetrical similar subunits oriented 180° to one another, each
with two lobes that together form a clamshell. Lobe 1 and lobe 2 of eachi-Porter).
lsevier B.V.subunit approach each other, and their intersection forms the cleft that
binds ligand. The amino acid sequences of the VFTMs of T1R andmGluR
have ~25% identity and ~41% similarity, and the predicted secondary
structural features (helices and beta strands) of the extracellular
domains of T1Rs match those found in the crystal structure of
mGluR1. Thus, T1Rs and other family C GPCRs are expected to dimerize
and to bind ligand in a manner similar to mGluR1. The conformational
change in family C GPCRs that takes place upon ligand binding appears
to be transmitted from the VFTM and CRD to the TMD helical bundle,
then onward to the cytoplasmic surface, where it contacts and activates
the G-protein. In the heterodimeric sweet receptor the conformational
change is apparently transduced from the VFTM of T1R2 to the TMD
helical bundle of T1R3 (Fig. 1). This specialization of subunits is
reminiscent of GABAB receptors, in which one subunit binds the ligand
while the other transmits the signal to the coupled G-protein [9,10].
T1R2+T1R3 are the primary receptors for a diverse range of sweet
ligands [1–3]. Calcium imaging assays of HEK cells transfected with
hT1R2+hT1R3 respond to all sweet taste stimuli tested, including
sugars, amino acids, sweet proteins, and synthetic sweeteners
[1,3,11–13]. All of these responses are inhibited by the sweet taste
inhibitor lactisole, which acts on the transmembrane domain (TMD)
of T1R3 [12,14,15].
1.2. Sweet proteins
Over the last three decades a number of high potency, naturally
occurring, sweet-tasting proteins have been isolated from a variety of
African and South Asian fruits. The ﬁrst sweet protein to be identiﬁed
Fig. 1. Scheme illustrating interactions between the heterodimeric sweet receptor and
sweet ligands in our heterologous expression assay. In the calcium-sensitive dye-based
assay, ligand binding to themembrane-bound sweet receptor is detected as an increase in
cytoplasmic calcium due to the action of receptor-induced G-protein activity. The sweet
receptor undergoes a conformational changeupon ligandbinding that leads to subsequent
activation of a modiﬁed promiscuous Gα protein (G16) that has the receptor-interacting
domain substituted with the taste cell G-protein gustducin's C-terminal 44 amino acids
(Gα16-gust44). This creates a G-protein with speciﬁcity for the sweet receptor, but which
activates anendogenous calciummobilizationpathway in thehostHEKcells. The activated
reporter G-protein stimulates release of calcium stores into the cytoplasm via its βγ
subunitswhichactivate thePLC/IP3pathway. The resulting increase inCa2+concentration
is monitored by cell permeable calcium-sensitive ﬂuorescent dyes.
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(11,086 Da) [17], mabinlin (12,441 Da) [18], brazzein (6,473 Da) [19]
and neoculin [20]. Sweet proteins have a sweetness ranging from300 to
3000 times that of sucrose on a weight basis.
Although sweet proteins exhibit no sequence or structural homol-
ogy, they all require charged residues (speciﬁcally positively charged
residues) on the protein surface over a non-continuous area for sweet
activity. Thus, it may be that protein sweeteners share a yet-to-be
identiﬁed receptor bindingmotif and interactwith the sweet receptor in
a similar, but not identical, manner.
Interestingly, human-speciﬁc sweet proteins, such as brazzein,
interact with human T1R2+T1R3 receptors but not rat [2] or mouse [3]
T1R2+T1R3 receptors. Rodent and human T1Rs exhibit 70% sequence
identity [1]. These ﬁndings opened up an avenue for elucidating the
mechanisms of human sweetener–receptor interactions and the
resulting signal transduction.
1.3. Brazzein
Brazzein is the sweet-tasting protein that occurs naturally in the
fruit of the African plant Pentadiplandra brazzeana Baillon. Brazzein is~2000 times sweeter than sucrose on a weight basis (17,000 times
sweeter than sucrose on a per-molecule basis) [19,21,22]. The protein
contains no carbohydrate and bears no structural resemblance to
sucrose. The species difference in brazzein's perceived sweetness
makes it an attractive compound with which to deﬁne the sweet taste
receptor ligand-binding sites. Our current hypothesis is that brazzein
binds to a non-continuous, multisite, multidomain surface that
includes the “hinge” region of T1R2 and the CRD of T1R3. The
brazzein binding site is distinct from the sucrose binding site, but,
nevertheless, both sweeteners trigger a conformational change on the
pathway leading to the sweet taste response (Fig. 2) [3,22,23].
1.4. Brazzein stimulation of human T1R2+T1R3
Recently, a cell-based calcium mobilization assay for sweetener–
receptor activity was developed that employs human T1R2+T1R3
sweet receptors expressed heterologously in HEK293 cells [3,12,13].
HEK293 cells are co-transfected with plasmids containing the cDNA
for the human versions of T1R2 and T1R3 and the promiscuous
chimeric G-protein reporter G16gus44 (Fig. 1). The cells contain, in
addition, a plasmid with cDNA encoding red ﬂuorescent protein as a
means for identifying transfected cells. Responses to sweet ligand
activation of receptors are monitored by calcium mobilization
imaging using the calcium indicator dye ﬂuo-4 acetoxymethyl ester.
This approach allows quantitative measurement of the activity of the
sweet receptor in response to an array of sweet ligands. The activity
assay has been useful for analyzing the functional properties of wild
type and mutant sweet receptors in response to sweeteners, but it
does not provide information about the status of ligand binding in
those receptormutants that are defective in their response tomultiple
sweet ligands.
1.5. Mutagenesis studies of brazzein interaction with the CRD of T1R3
Jiang et al. [3] showed that the CRD of hT1R3 contains residues
critical for its interaction with the sweet protein brazzein. Because
brazzein's sweetness is speciﬁc to humans and old world primates
(but not to mice), the heterologous expression in HEK cells of various
combinations of human and mouse T1R receptors was used, along
with a reporter G-protein, to determine whether responses to
brazzein require that the T1R3 monomer be of the human type.
To locate the residues of hT1R3 required for responsiveness to
brazzein, several human/mouse chimeras were constructed and
tested in combination with hT1R2 [3]. Within the critical region of
the CRD, only ﬁve amino acids differ between mT1R3 and hT1R3. A
single-site human-to-mouse mutant (A537T) was found to be
unresponsive to brazzein. In addition, a nearby mutant (D535Q)
was found to abolish the ability of brazzein to activate the receptor,
but spared responsiveness toward cyclamate (which binds in the TMD
of T1R3) and toward other small molecule sweeteners that bind
within the VFTM [24]. These results identiﬁed a critical contact site on
the CRD of T1R3 for brazzein and likely for other protein sweeteners
(the response to monellin also is reduced by mutations in this region
of the receptor). Protein modeling studies have shown that residues
critical for brazzein activity all lie on the same face of the CRD [24,25].
1.6. Saturation transfer difference (STD) investigations of the interaction
of sweeteners with the sweet taste receptor
The work described above set the stage for the possibility of
carrying out NMR experiments aimed at the direct detection of
interactions between sweeteners and the human sweet receptor
expressed in HEK cells [23]. We describe these experiments here and
their implications for future experiments of this kind between
receptors and small molecules that alter their function.
Fig. 2. Surface representation of brazzein showing the three major putative receptor
binding sites (side chains shown in color are from residues found to be important for
sweetness). Site 1: includes Loop43 at end of an antiparallel β-hairpin and contains
mostly charged and aromatic residues. Site 2 includes the N- and C-termini and
contains the cluster of acidic residues shown in red [22]. Site 3: includes Loop19 and is
located near Loop43 (site 1).
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2.1. Preparation of membranes containing the sweet receptor
Wild-type hT1R2+hT1R3 and mutant hT1R2+hT1R3(D535Q)
were co-expressed in HEK293 EBNA (HEK293E) cells. The level of
protein production was determined by immunostaining against the
ﬂag epitope tag inserted at the C-terminus of the T1R2 construct and
against an antigenic peptide located the VFTM of T1R3. Membranes
used in NMR experiments were isolated from parental cells, from
stable cell lines expressing wild-type hT1R2+hT1R3/Gα16-gust44
(generated by clonal dilution under hygromycin (500 g/ml) and
Zeocine (100 g/ml) selection), or from HEK cells transfected with
other T1R# plasmid(s) of interest. The parental cells were HEK 293
cells subjected to mock procedures.
Lipofectamine™-2000 (Invitrogen, Carlsbad, CA) was used to
transfect 293 E cells according the manufacturer's protocol. After
48 h, the cells were harvested from the ﬂask and spun at 800×g for
10 min in phosphate buffered saline containing 0.5 mMEDTA to pellet
the cells. The cells were transferred into homogenization buffer
containing 20 mM Tris–HCl (pH 7.4), 10% glycerol, and Complete™
Protease Inhibitor Cocktail (Roche, Nutley, NJ) and dispersed in a
Polytron homogenizer (Glen Mills, Clifton, NJ). Particulate matter was
removed by centrifuging at 1500×g for 15 min. The supernatant was
then centrifuged at 100,000×g for 1 h at 4 °C. The pellet was washed
with homogenization buffer lacking protease inhibitor and centri-
fuged at 100,000×g for 30 min at 4 °C. 200 μl of homogenization
buffer lacking protease inhibitor was added to the pellet, and the
membrane was resuspended by 20 passages through a 25 gauge
needle. The membrane suspension was stored at −80 °C until used.
2.2. Preparation of brazzein
The construct used to produce brazzein in E. coli cells was an
artiﬁcial gene coding for des-pGlu1-brazzein joined to the gene
coding for SUMO followed by a His-tag [26]. The brazzein-SUMO
fusion protein was produced under the control of a T7 promoter from
BL21(pLysS)-PRIL-CodonPlus cells with induction by 0.5 mM IPTG.
Following induction, cells were grown for 24 h at 25 °C. Cells were
harvested by centrifugation and disrupted by sonication, and thesoluble fraction was applied to a Ni+-NTA column to isolate the fusion
protein. SUMO protease (1U/50 μg fusion) was added to cleave
brazzein from the rest of the protein. The SUMO protease (a small
ubiquitin-like modiﬁer) recognizes only the tertiary sequence of
SUMO and efﬁciently cleaves at the junction between SUMO protein
and brazzein. The cleavage yield was N90% in the presence of 0.1 mM
DTT. Brazzein was puriﬁed from the cut and uncut fusion protein by
reversed-phase HPLC [26]. The concentration of brazzein was
determined by measuring the absorbance at 205/280 nm [26].
2.3. NMR sample
The 150 μl NMR sample contained 2 mg brazzein and 50–75 μg
membrane. The receptor concentration was estimated to be in the nM
range. Thus the ligand to receptor ratio was ~500:1. Although this
ratio is higher than those previously reported in the literature for STD
NMR experiments, the membrane-bound receptor has a very long
correlation time, which yields a much higher STD ampliﬁcation than a
protein in solution.
2.4. NMR data collection and analysis
Two-dimensional STD 1H–15N HSQC data were collected on a
800 MHz Varian VNMRS spectrometer equipped with a cryogenic
probe. Datawere collected at 298 Kwith 96 accumulations per FID and
1024×32 complex points in the direct (1H) and indirect (15N)
dimension, respectively, for a total acquisition time of 9 h for each
2D experiment. The receptor-saturated spectrum was obtained by
applying a 3-s continuous-wave pulse with a 50 Hz ﬁeld strength at
−1.0 ppm (where brazzein has no 1H signal) prior to the ﬁrst pulse of
the HSQC sequence. On alternate scans, the reference spectrum was
collectedwith the saturation pulse shifted to 50 ppm (well beyond the
1H spectral region of both brazzein and receptor). The STD spectrum
was obtained by subtracting the two signals. This procedure was used
to collect STD spectra from a sample containingmembranes from HEK
cells expressing the wild-type sweet receptor (hT1R2+hT1R3),
membrane from cells expressing the mutant (hT1R2+hT1R3
(D535Q)), and membrane from parental cells (cells lacking the
expression plasmids). As a means for removing signals arising from
non-speciﬁc binding, the STD spectrum from parental cell membranes
was subtracted from the STD spectrum of each receptor-containing
membrane preparation to yield the ﬁnal saturation transfer double
difference (STDD) spectra.
3. Results and discussion
3.1. Monitoring ligand binding to T1R2+T1R3 by STD NMR spectroscopy
Previous studies of ligand binding to sweet receptors were
hindered by the low afﬁnity of the receptor for sweeteners [27,28].
Our novel assay for sweet receptor/ligand-binding interactions based
on saturation transfer difference (STD) and saturation transfer double
difference (STDD)NMR spectroscopywas found to be responsive even
for weakly binding sweeteners [23].
STD NMR is well established as a sensitive and powerful tool for
monitoring direct binding interactions of single or multiple ligands in
a complex system. Because the spectrum of the ligand is monitored,
the approach is not limited by the apparent molecular weight of the
receptor. Thus, we postulated that it could be used to study
interactions between receptors expressed and displayed on the cell
surface and soluble sweeteners. Although STD signals could be
detected with intact cells, we found that the sensitivity of the
experiment could be increased by using receptor–containing mem-
brane isolated from the cells [23]. This general approach can be used
to obtain important information about ligand-receptor interactions.
1) It provides information about ligand afﬁnity and the nature of the
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interaction in competitive or noncompetitive circumstances based on
equilibrium constants (the association constant Ka or dissociation
constant Kd) and on- and off-rates (kon and koff). 3) The method can
be used to examine the properties of truncated or full-length hetero-
or homodimeric receptors in cells (in vivo) under physiological
conditions or in a membrane environment. 4) Only a very small
amount of receptor (pmol–μmol) is required for this assay.
Previously, it was shown that STD NMR could be applied to
platelets [29]. Thus, cells displaying receptors on their surface at
normal heterologous expression densities are ideal substrates for
monitoring ligand-receptor interactions by STD NMR. As explained in
more detail below, binding is detected from changes in the signal of
free ligand which, depending on Kd, is adjusted to have a concentra-
tion 20–1000-fold greater than that of the receptor protein [30]. The
preferred receptor concentration for STD NMR experiments is
nM–μM. From our histocytochemical assays for cell surface localiza-
tion of receptors we estimate that the membranes contain 1–10 nM
receptor [29]. We adjusted the ligand and receptor concentrations for
maximal complex formation according to,
½L + ½P⇄kon
koff
½C
where L stands for ligand, P for protein receptor, C for the ligand-
receptor complex, and kon and koff are the association and dissociation
rate constants. The STD NMR technique relies on spin diffusion to
transfer saturation from the receptor to the bound ligand [30,31]. TheFig. 3. Two-dimensional 1H–15N HSQC saturation transfer difference (STDD) results repor
(B) brazzein-defective hT1R2+hT1R3(D535Q) mutant receptor in membranes isolated fr
spectrum was obtained by subtracting the STD signals of HEK cells without expressed recep
the top of each panel is a projection of the 2D spectrum along the 1H NMR dimension to allow
each peak comes from individual backbone 1HN–15N. The decreased peak intensity in 2D spsaturation spectrum is obtained by applying a saturating pulse to a
region of the receptor spectrum that is far from any ligand resonance
(here we irradiated at −1 ppm). For large proteins, such as the
heterodimeric sweet receptor, efﬁcient spin diffusion rapidly pro-
duces a state of saturation throughout the protein [30,31]. Spin
diffusion also causes signals from the ligand to become saturated
during transient binding to the receptor. As the saturated ligand
molecules are released in solution, new molecules are bound and
saturated, causing the pool of free ligand to become gradually
saturated. A control spectrum is then taken with the saturating pulse
applied outside the spectral regions of the receptor and ligand (here
we used 50 ppm). The control spectrum is then subtracted from the
saturation spectrum to yield the STD spectrum, which reveals the
saturation transferred to the pool of free ligand.
The degree of saturation depends on the ratios of the con-
centrations of L and P and on the dissociation constant. We were able
to achieve suitable conditions by using membrane protein con-
centrations of 7.5–10 μg/μl (roughly in the 1–10 nM concentration
range). The ratio of ligand to receptor for known Kd values for
lactisole, cyclamate, alitame, and brazzein indicated that we could
achieve the right concentration range simply by adjusting the
membrane concentration [23]. To account for STD signals arising
from non-speciﬁc interactions between brazzein and cell membranes,
we ran additional STD experiments using membranes derived
from parental HEK cells that do not express the sweet receptor.
Subtraction of this STD spectrum from those of receptor-containing
membranes yielded STDD spectra containing signals only from
speciﬁc binding.ting on the interaction of wild-type brazzein with (A) wild-type hT1R2+hT1R3 and
om HEK293 cells expressing and displaying the sweet receptor (HEK+r). Each STDD
tor (to remove effects from non-speciﬁc binding) from the STD spectrum of HEK+r. At
for a better comparison of signal intensity between the two spectra. In the 2D spectrum,
ectrum B compared to A indicates a signiﬁcant loss of binding afﬁnity.
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Previousmutagenesis studies had identiﬁed amutant of T1R3with
a “brazzein-speciﬁc binding deﬁcit”, hT1R3(D535Q). Because this
mutation was found to impair activation of the receptor by brazzein
but not by cyclamate or other sweeteners that bind within the Venus
ﬂytrapmodule (VFTM) [31], it appears to identify a critical contact site
for brazzein on the CRD of T1R3. Thus, to investigate the role of this
mutation on its ability to alter brazzein binding, we designed STD
NMR experiments to test the binding between the wild type or the
hT1R2+hT1R3(D535Q) mutant form of the sweet receptor with
wild-type brazzein. Because signals from larger ligands such as
brazzein are more complex to analyze, we developed and utilized a
two-dimensional version of the STD experiment (2D-STD 1H–15N-
HSQC NMR). The 2D-STD NMR experiments (Fig. 3) clearly showed
that mutant human receptor (T1R2+T1R3(D535Q)) binds brazzein
much less tightly than wild-type receptor (T1R2+T1R3).
4. Conclusions and future prospects
The sweet receptor is involved in sensation of a wide variety of
chemically and structurally diverse sweet molecules (N50). We have
monitored the direct ligand binding of a set of sweeteners to the
human taste receptor in membranes prepared from HEK293 cells.
Our results show that the saturation transfer NMR binding assay can
be used to monitor speciﬁc ligand–receptor binding interactions
with both small ligands (lactisole, cyclamate, alitame) and a sweet
protein (brazzein) [23]. In addition, the results of our binding
assay conﬁrm earlier mutagenesis and modeling data that suggested
that the loss of activity of the CRD of T1R3(D535Q) mutant is due
to disruption of the brazzein binding site. The STD NMR method
provides a powerfulwayof identifying andmapping ligandand receptor
binding sites, and it should prove to be valuable for determining the
molecular mechanisms for ligand binding and consequent signaling
events.
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